University of California San Francisco
Give to UCSF
UCSF researchers have discovered that a key cellular defect that disturbs the production of proteins in human cells can lead to cancer susceptibility. The scientists also found that a new generation of inhibitory drugs offers promise in correcting this defect.
UCSF scientists have discovered how a mutated gene known as Kras is able to hijack mouse cells damaged by acute pancreatitis, putting them on the path to becoming pancreatic cancer cells.
New UCSF clinical trial tests intermittent high-dosage treatment for HER2-positive breast cancers.
A panel of experts appointed by Mayor Gavin Newsom recently presented an action plan as the approaching “age wave may bring a potential crisis in Alzheimer’s and dementia care” to San Francisco.
UCSF researchers have identified a molecular mechanism that explains why patients with tumors of the thymus, or thymoma, often develop autoimmune disorders.
A new discovery about cancer and the immune system points to previously unrecognized targets for drug development to battle solid tumors.
Cancer researchers studying the immune system have identified a previously unrecognized set of targets and biomarkers to battle solid tumors.
Walter S. Newman, a leading San Francisco businessman, philanthropist, and community leader, has joined the Board of Directors of NCIRE-The Veterans Health Research Institute.
Senator Arlen Specter will join UCSF Chancellor Sue Desmond-Hellmann for a town hall meeting to talk about health care reform, federal funding of scientific research and other important issues on February 16.
UCSF Chancellor Susan Desmond-Hellmann outlines a vision for faster development of better, cheaper drugs to fight cancer.
A UCSF analysis of published studies on the relationship between Alzheimer’s disease and smoking indicates that smoking cigarettes is a significant risk factor for the disease.
UCSF experienced the highs and the lows of 2009, a year that marked the beginning of a leadership shift at the health sciences University.
Cancer survivor David Servan-Schreiber, a physician, neuroscientist and science writer, will speak about preventing and treating cancer at UCSF on Friday, Jan. 15.
The UCSF community is invited to hear UC Irvine Chancellor Michael Drake, a longtime UC leader and champion of diversity, deliver the keynote address on Friday during Martin Luther King, Jr. events.
The Martin-O’Neil Cancer Center at St. Helena Hospital and the UCSF Helen Diller Family Comprehensive Cancer Center at UCSF Medical Center have begun an affiliation that will provide North Bay patients with access to clinical research trials and express referrals to cancer specialists through a convenient Napa Valley location.
The use of computed tomography (CT) scans in medicine to diagnose disease, and in many cases save lives, has exploded in recent decades.
UCSF officials are confident that UCSF Medical Center at Mission Bay will open its doors to women, children and cancer patients by late 2014.
Radiation doses from common CT procedures vary widely and are higher than generally thought, raising concerns about increased risk for cancer, according to a new study led by UCSF imaging specialists.
UCSF researchers have discovered inherited DNA that increases risk for the most deadly brain cancers.
Faculty, staff, friends and supporters gathered Tuesday for the opening of the Helen Diller Family Cancer Research Building, the fourth research facility to open on the Mission Bay campus.
The opening of a new cancer research building tomorrow at Mission Bay represents the “manifestation of a vision our outstanding cancer specialists have been working toward for more than a decade,” says Chancellor Mike Bishop.
UCSF officially opened the Helen Diller Family Cancer Research Building on its Mission Bay campus today with a ribbon-cutting and open house highlighting a new vision for cancer research, treatment, and prevention.
The Multiple Myeloma Translational Initiative (MMTI) aims to promote collaborative research efforts and accelerate the transition of promising cancer therapies from the lab to the hospital.
A nationwide study of over 280,000 women showed that postmenopausal women who are overweight or obese have advanced breast cancer at significantly higher rates than women of normal weight or less than normal weight.
A gift of $35 million--the largest contribution from individual donors in UCSF history--has been made by the Helen Diller Family to support construction of a new cancer research building at UCSF Mission Bay.